000			01472 a2200469 4500
005			20250513155625.0
264		0	_c19990205
008			199902s 0 0 eng d
022			_a0006-4971
040			_aNLM _beng _cNLM
100	1		_aHägglund, H
245	0	0	_aNorethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. _h[electronic resource]
260			_bBlood _cDec 1998
300			_a4568-72 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aBone Marrow Transplantation _xadverse effects
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHeparin _xtherapeutic use
650	0	4	_aHepatic Veno-Occlusive Disease _xchemically induced
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aInfant
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNorethindrone _xadverse effects
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aSurvival Rate
700	1		_aRemberger, M
700	1		_aKlaesson, S
700	1		_aLönnqvist, B
700	1		_aLjungman, P
700	1		_aRingdén, O
773	0		_tBlood _gvol. 92 _gno. 12 _gp. 4568-72
999			_c9808656 _d9808656